1 Farmacogenetica 10 jaar ervaring met klinische implementatie Prof Dr Ron van Schaik Hoogleraar Farmacogenetica (Inter)Nationaal Expertise-Centrum Farmacogenetica Afd. Klinische Chemie - Erasmus MC Rotterdam (ISO15189) Den Haag, 15-09-2016 Full Professor Pharmacogenetics Clinical Chemist (EuSpLM) Dept .Clinical Chemistry, Erasmus MC Rotterdam (and UMC Utrecht) Director International (IFCC) Referencecenter Pharmacogenetics International Commities: International Federation Clinical Chemistry (IFCC): Task Force Pharmacogenetics (chair) European Society for Pharmacogenomics & Personalized Therapy (ESPT): President American Association Clinical Chemistry (AACC): Personalized Medicine Division (Board) European Medicine Agency (EMA): Pharmacogenetics Working Group (Advisor) European Pharmacogenetics Implementation Consortium (Eu-PIC): chair Other: IUPHAR, IATDMCT, EUSPM, Genomic Med. Alliance, EPRN, CPIC, Golden Helix National Commities: Dutch Society Clinical Chemistry (NVKC): Comm. Molecular Diagnostics (chair) Dutch Society Clinical Chemistry (NVKC): Task Force Pharmacogenetics (chair) Royal Dutch Pharmacy Society (KNMP): Workinggroup PGx Dutch Clinical Pharmacogenetics Network (NKFN): chair KNMP / NVZA / NVKC Collaboration Committee: chair FARMACOGENETICA DNA onderzoek ter verklaring / ter voorspelling van de reactie op geneesmiddelen Personalized Medicine President Obama, State of the Union 2015 Tonight (Jan 2015) I am launching the Precision Medicine Initiative: $215.000.000
8
Embed
FARMACOGENETICA DNA onderzoek ter / ter voorspelling · FARMACOGENETICA DNA onderzoek ter verklaring / ter voorspelling van de reactie op geneesmiddelen Personalized Medicine President
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Farmacogenetica10 jaar ervaring met klinische implementatie